Skip to main content

Home/ health information/ Group items tagged 22

Rss Feed Group items tagged

pharmacybiz

Revolutionary Gender Services Launching in London & Liverpool - 0 views

  •  
    London's Great Ormond Street Hospital and Alder Hey Children's Hospital in Liverpool are poised to introduce groundbreaking gender-related services in England, following the closure of the Gender Identity Development Service (Gids) operated by the Tavistock and Portman NHS Foundation Trust. Amid concerns expressed by hospital executives regarding the closure of Gids, with leaked emails revealing apprehensions about appointment cancellations and inadequate communication with the new services, the National Health Services England (NHSE) has confirmed "its commitment to ensuring continuity of care for patients already accessing endocrine care in GIDS." NHSE's decision to transition to regional services stems from a 2022 interim review, led by Dr. Hilary Cass, which highlighted the need for improved support structures for gender-distressed youth. It emphasized a significant increase in referrals to Gids, surpassing 5,000 in 2021/22, compared to less than 250 a decade ago.
pharmacybiz

Poverty's Toll on Health: NHS Crisis Revealed - 0 views

  •  
    Poverty not only takes a significant toll on people's health but also leads to additional costs for the National Health Service (NHS). Rise in deep poverty, cost-of-living crisis, and high pressure on NHS services have worsened the situation, according to a study published by The King's Fund this week. The report underscored that poverty and deprivation contribute to a greater prevalence of diseases, difficulties in accessing health care, late or delayed treatment, and worse health outcomes. These challenges could be seen across various NHS services, spanning from emergency care to dental services Additionally, it revealed that 30 per cent of people living in the most deprived areas have turned to 999, 111, A&E or a walk-in centre because they could not access a GP appointment. In 2016, the Joseph Rowntree Foundation (JRF) estimated the cost of poverty on health care at £29 billion (£34 billion in current prices). As the proportion of people living in deep poverty has risen, the situation has worsened. In 2021/22, six million people were living in very deep poverty, up from 4.5 million two decades ago. Currently, more than one in five people in the UK are estimated to be living in poverty, the report noted. Deprivation is linked to a range of diet-related health problems, including cardiovascular disease and diabetes, as well as mental illness. According to the report, the depression rate is two times higher among people living in the most deprived areas, compared to the least deprived areas.
pharmacybiz

JAS Healthcare Unit Granted WDA(H) License for Pharma Excellence - 0 views

  •  
    Global logistics company, JAS has received the Wholesale Distribution Authorisation (WDA(H)) license from the UK's Medicine and Healthcare Products Regulatory Agency (MHRA) for its Pharma and Healthcare Division. In a press release issued on Thursday (22 February), the company said that securing the license empowers its UK healthcare division to "seamlessly connect" with its more than 40 GDP (Good Distribution Practice) certified overseas stations, strengthening its capabilities for handling pharmaceutical shipments. Headquartered in Atlanta, Georgia, USA, the company boasts a team of over 7,000 professionals, with operations spanning over 100 countries. Adrian Frodsham, Regional Director for JAS, said that they were granted the WDA(H) license after a "stringent audit process." "JAS UK's pharma and healthcare division prides itself of offering innovative solutions for the international delivery of pharmaceutical products, further enhancing the growth of our pre-established healthcare division," he added.
pharmacybiz

NHS Introduces World-First Genetic Test for Sickle Cell and Thalassaemia - 0 views

  •  
    The UK's National Health Service (NHS) has become the first healthcare system in the world to provide a new blood group genotyping test for people with rare inherited blood disorders. From Monday (22 January), thousands of patients suffering from sickle cell disorder and thalassaemia will get access to the world-first 'blood matching' genetic test, which will help reduce their risk of transfusion side effects while offering more personalised care. In England, it is estimated that around 17,000 people are living with sickle cell disorder, with 250 new cases reported each year, and there are about 800 thalassaemia patients, with less than 50 new cases a year. Health Minister Andrea Leadsom said: "Thousands of people living with sickle cell disease and thalassaemia will be eligible for this new world-first blood test which is set to transform their care.
robert1488stp

9th Annual MarketsandMarkets High Potent Medicines Conference | eMedEvents - 0 views

  •  
    MarketsandMarkets Conferences is Organizing the 9th Annual High Potent Medicines Conference - EU Edition which will be held from May 22 - 24, 2024 in Milan, Italy.
pharmacybiz

Closing Pharmacy Gaps: RPS Report Urges Action for Black Trainees - 0 views

  •  
    The Royal Pharmaceutical Society (RPS) has called for action on differential degree awarding and registration assessment attainment gaps for Black trainees in initial pharmacy education and training. According to a new report published by the RPS on Tuesday (6 February), there's a pharmacy degree awarding gap of eight per cent and a registration assessment attainment gap of over 22 per cent between Black and White trainees. The variation in pharmacy attainment for Black trainees was first recorded by the General Pharmaceutical Council (GPhC) in 2013, and the Pharmaceutical Journal has been tracking the awarding gap at undergraduate level. Even after a decade, significant differences exist in the awarding and attainment gaps for Black students and trainees compared to their White counterparts, the report said.
pharmacybiz

Insect Bites and Stings: NHS England Reports 162% Increase - 0 views

  •  
    Insect bites and stings typically increase in the summer in England. This year, however, there's been an earlier-than-usual spike in the number of people seeking NHS advice on the condition. According to the NHS England, visits to its insect bites and stings web page have nearly tripled in the last three weeks compared to the same period last year, peaking at an average of one visit every 22 seconds in the past week. Over the span of 21 days, a total of 68,986 visited the page, marking a significant 162 per cent increase compared to the 26,368 visits recorded in the first three weeks of May 2023. Although insect bites or stings are usually not serious and people tend to get better after a few days, the health service has cautioned that they can lead to infection or severe allergic reactions. People are encouraged to refer to the NHS website for advice or visit their local pharmacy to get advice and treatment for common health conditions, including infected insect bites.
pharmacybiz

Whooping Cough Surge: NHS Reactivates Clarithromycin SSPs UK - 0 views

  •  
    As whooping cough cases rise sharply across the UK, the NHS has reactivated the serious shortage protocols (SSPs) for clarithromycin - a commonly prescribed antibiotic to treat this bacterial infection. Pharmacy bodies had recently warned that community pharmacies were struggling to obtain source clarithromycin for patients. Two SSPs, covering clarithromycin 125mg/5mL and 250mg/5mL oral suspensions, were reactivated on 22 May 2024, and extended until 21 June 2024. These protocols state that for every 5mL of clarithromycin 125mg/5mL oral suspension, pharmacy contractors must supply 2.5mL of clarithromycin 250mg/5mL oral suspension; and for every 5mL of clarithromycin 250mg/5mL oral suspension, one clarithromycin 250mg tablet must be supplied. The SSPs apply to cross-border prescriptions, both NHS and private.
pharmacybiz

Covid-19 Inquiry: NPA Highlights Areas Of improvement in Vaccination Programme - 0 views

  •  
    The National Pharmacy Association (NPA) views the COVID vaccination programme as broadly successful, largely due to the efforts of healthcare workers and volunteers. However, it cited some areas that could be improved, notably the early involvement of community pharmacies in planning, operational challenges, and recognising the role of community pharmacy in addressing vaccine hesitancy and inequalities. Submitting its evidence to the Covid-19 Inquiry, the NPA highlighted that the community pharmacy should have been consulted and involved earlier in the planning process, considering their two years of experience and expertise in administering annual influenza vaccination programs and the reach and resources of the 14,000 community pharmacies across the UK. "Instead, community pharmacy was initially given a gap in service role, which failed to fully utilize their experience, expertise and resource," Lawyer Brian Stanton told the Inquiry on behalf of the NPA during the Module 4 Preliminary Hearing on 22 May.
pharmacybiz

Combating Loneliness in the UK: Women's Health Initiatives 2024 - 0 views

  •  
    Despite being more connected than ever, the majority of Europeans are experiencing feelings of loneliness. The STADA Health Report 2024, released on Monday, revealed that over half (52 per cent) of Europeans "always, often or occasionally" feel lonely. Although the younger generation reports the highest levels of overall happiness, they are the ones most affected by this current loneliness epidemic. Nearly two-thirds (63 per cent) of Europeans aged 18 to 35 reported feeling lonely, compared to 41 percent of those aged 55 and older - according to the report, based on a survey of over 46,000 respondents aged 18 to 99 across 32 countries. Extensive screen time is contributing to increased loneliness among younger people. Europeans under the age of 34 are much more likely to spend long hours on their devices (41 per cent) than those aged 35-54 (22 per cent) and those over 55 (13 per cent). The survey found that people who spend a "long" or "fair" amount of time on social media were significantly more prone to feelings of loneliness compared to those who restrict their screen time. Moreover, extensive screen time was also associated with more intense feelings of loneliness.
Nguyễn Thư

Mì cay và nguyên nhân gây đau dạ dày - 0 views

image

healthy health h

started by Nguyễn Thư on 12 Jul 16 no follow-up yet
wheelchairindia9

Tynor Hot and Cold Pack - 0 views

  •  
    Tynor Hot and Cold Pack is a convenient device to provide hot fomentation or cold compress. Tynor Hot and Cold Pack is of multipurpose advantage. It is a convenient and effective approach for both hot as well as a cold therapy. Hot pack can be used for body ache, joint pain, etc., whereas a cold pack can be used for fever, sprains, fever, bleeding, etc. It is easy to use and maintains the temperature for a long period of time. It is available in 11.22 x 7.67 inch universal sizes. Hot fomentation of the injured or inflamed area enhances the threshold of pain and thus reduces the perception of pain. It has a synergistic effect along with pain relieving drugs. Raising temperature of the injured tissue also enhances the blood profusion and the healing process. Hot fomentation has a relaxing effect. Cold compress helps in reduction of inflammation in injuries, protects by slowing the metabolic rate around the tissue, reduce oedema and bleeding. Cold compress helps in immediately lowering fever, in very high fever conditions. It can be used after an acute injury or surgical procedure. No heat or cryo burns. Requires no holding. Reusable. Easy application. Appealing aesthetics. Tynor Hot and Cold Pack Features Multi functionality Reduce swelling and odema at the site of injury. Muscles spasm and pain. Headache and minor injuries. Versatile design Can be used as either cold or hot pack. Reusable in either hot & cold condition. Temperature range - Can be used from 0 Cº to 75Cº. Longer temperature retention time. Fabric cover ensures no cryo burns or hot skin burns. Physical features Non-toxic, and biodegradable. Gel remains soft and flexible upto 0 degree. Durable, and puncture resistant. Soft, "frost free" PVC cover. Flexible conforms to the body contours. Easy to clean and maintain. Excellent workmanship. Good aesthetics. Elastic belt Holds the pack against the body, No need to hold by hand. Enhances convenience. Tynor
anonymous

Karma 8020 Wheelchair - 0 views

  •  
    This overwhelming obligation wheelchair will be committed for overwhelming weight users, alternately individuals who bring endured from thoracic or spinal damage Furthermore can't move in What's more out of the wheelchair undoubtedly. It camwood make upto 160 kgs for client weight Consequently suits overweight client. Both the arm and the leg r would swing out sort , settling on moving in and crazy of the wheelchair less demanding. It may be An lighweight overwhelming obligation wheelchair (17 kgs) camwood a chance to be collapsed Furthermore taken effectively. Agreeable upholstery makes utilizing this wheelchair simple.
anonymous

Soma SM 100.3 @ Rs 9751 : Karma Soma Transit Wheelchair : Karma Soma Manual Wheelchair ... - 0 views

  •  
    The SM-100.3 is an aluminum alloy standard wheelchair that is economic, solid, and durable. A Standard wheelchair is lightweight and manageable by people with good upper body strength and balance. Soma SM 100.3 highly adjustable and can be used by patients with different injuries and disorders. Standard wheelchairs allow easy movement and rotation of wheels. Health Vistas offer Standard wheelchairs from brands Karma Healthcare and Smart Care that provide high comfort and have durable finish.
anonymous

Soma SM 150.3 @ Rs 9751: Soma Wheelchairs : Soma 150.3 Karma Wheelchair : Soma Wheelcha... - 0 views

  •  
    karma Soma SM 150.3 Lightweight Wheelchair KARMA Aircraft-Grade Aluminum Wheelchair SM 150.3 F16 is an aluminum alloy standard wheelchair that is economic, solid, and durable. The SM-150 offers the lightest weight, general purpose chair on the market with fixed arm and leg-rests and folding back rest. Ultra-lightweight aircraft-grade aluminum alloy frame. Standard seat width is 17". The unique and stylish elliptical frame ensures that the chair is both rigid and robust.
Ian Caspar

Travel sickness and dealing with it - 0 views

  •  
    Tablets and patches are available for people who experience sickness while travelling. They are effective treatments for travel sickness, a common problem experienced by people while travelling. Read further to learn more about these medications.
Bruce Pinta

The Trivedi Effect® - A Ray Of Hope For Dealing With Hopelessness - 0 views

  •  
    Dealing with hopelessness can be really tough. Connect to the inner guidance through the Trivedi Effect and welcome a new life.
Alex Parker

Novartis reshapes business by signing deals with GSK, Eli Lilly - 2 views

  •  
    PBR Staff Writer Published 22 April 2014 Swiss pharmaceutical firm Novartis has entered into a definitive agreement to acquire the oncology unit of Britain's GlaxoSmithKline (GSK) for about $14.5bn and up to $1.5bn contingent on a development milestone. As part of the deal, Novartis would have opt-in rights to GSK's current and future oncology R&D pipeline.
Willow O'Donnell

Buy And Sell Your Medical Equipment And Always Stay Supplied - 0 views

  •  
    Buying medical supplies should be done in specialized stores which will be bound to sell you only the safest and sterilized equipment. Medical supplies nowadays include much more than your average first aid kit.
« First ‹ Previous 101 - 120 of 138 Next ›
Showing 20 items per page